Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mania and Antimanic Drugs: Overview

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...

Bipolar Disorder

Bipolar Disorder

Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.

Psychosis: Goals of Pharmacotherapy

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

Depression: Overview

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Do We Really Care About Our Children's School Safety? The Proof Is in the Pudding.

WMJ : official publication of the State Medical Society of Wisconsin·2026

Same author

Can You Properly Manage Delusional Parasitosis?

Innovations in clinical neuroscience·2025

Same author

Resurgence of polio and the path to eradication.

Tropical medicine & international health : TM & IH·2025

Same author

Babesiosis - An Unseen Epidemic.

WMJ : official publication of the State Medical Society of Wisconsin·2025

Same author

When Suicidality Is Suspected.

Southern medical journal·2025

Same author

Firearm Shootings: A Serious Public Health Issue.

Southern medical journal·2025

Same journal

Civil commitment in the United States.

Psychiatry (Edgmont (Pa. : Township))·2012

Same journal

Efficacy and Safety of Once- versus Twice-Daily Carbamazepine Extended-Release Capsules for the Treatment of Manic Symptoms in Patients with Bipolar I Disorder.

Psychiatry (Edgmont (Pa. : Township))·2012

Same journal

Management of depression: during pregnancy and the postpartum period.

Psychiatry (Edgmont (Pa. : Township))·2012

Same journal

Neurobehavioral problems associated with phenylketonuria.

Psychiatry (Edgmont (Pa. : Township))·2011

Same journal

Recommendation for DSM-V: A Proposal for Adding Causal Specifiers to Axis I Diagnoses.

Psychiatry (Edgmont (Pa. : Township))·2011

Same journal

The blood brain barrier and the role of ratiometric molecular analysis in schizophrenia.

Psychiatry (Edgmont (Pa. : Township))·2011

See all related articles

Search research articles

Related Experiment Videos

Managing bipolar depression.

Raymond Pary¹, Paul R Matuschka, Susan Lewis

¹Dr. Pary is Staff Psychiatrist; Dr. Matuschka is Clinical Coordinator, Pharmacy Service; and Dr. Lewis is with Mental Health and Behavioral Sciences-All from Veterans Affairs Medical Center, Louisville, Kentucky; Dr. Lippman is with the University of Louisville Hospital in Louisville, Kentucky.

Psychiatry (Edgmont (Pa. : Township))

|November 25, 2010

Summary

This summary is machine-generated.

Clinicians should thoroughly assess patients with depressive symptoms, including ruling out mania and assessing suicide risk. Treatment involves mood stabilizers, potentially with antidepressants, and cognitive behavioral therapy for optimal outcomes.

Related Experiment Videos

Area of Science:

Psychiatry
Clinical Psychology

Background:

Depressive symptoms require careful clinical evaluation to ensure accurate diagnosis and effective treatment.
Distinguishing between unipolar depression and bipolar disorder is crucial for appropriate management.

Purpose of the Study:

To outline a systematic approach for clinicians managing patients presenting with depressive symptoms.
To provide guidance on pharmacotherapy and adjunctive treatments for depression and bipolar disorder.

Main Methods:

Clinical assessment including patient history, functional impairment, and coexisting conditions.
Inclusion of collateral information from significant others.
Suicide risk assessment as a critical component of the evaluation.

Main Results:

Lithium remains a primary treatment for bipolar disorder due to its mood-stabilizing and suicide-preventative effects.
Lamotrigine shows efficacy in bipolar depression without a high risk of inducing mania.
Combination therapy with mood stabilizers and antidepressants is recommended; certain antidepressants (TCAs, MAOIs) should be avoided due to mania risk.

Conclusions:

A comprehensive diagnostic process is essential for patients with depressive symptoms.
Pharmacological management should prioritize mood stabilizers, with careful consideration of antidepressant augmentation and avoidance of certain classes.
Cognitive behavioral therapy can serve as a valuable adjunct to pharmacotherapy.